Microvascular Angina: Diagnosis and Management [PDF]
European Cardiology Review, 2021 Recognition of suspected ischaemia with no obstructive coronary artery disease – termed INOCA – has increased over the past decades, with a key contributor being microvascular angina.
Haider Aldiwani +3 more
doaj +4 more sources
Non-pharmacological Treatment of Refractory Angina and Microvascular Angina [PDF]
Biomedicines, 2020 Refractory angina (RA) is defined as debilitating anginal symptoms despite the optimal guideline-directed combination of medical, percutaneous, and surgical therapies.
Kudrat Rakhimov, Tommaso Gori
doaj +5 more sources
Microvascular angina in postmenopausal women.
Medisur, 2011 Background: Microvascular angina is common in postmenopausal women. Myocardial ischemia has been induced by stress testing, which has proved a relationship between endothelial dysfunction and myocardial perfusion defects.
Alexander Valdés Martín +1 more
doaj +4 more sources
Research Progress of Imaging Methods for Detection of Microvascular Angina Pectoris in Diabetic Patients [PDF]
Frontiers in Cardiovascular Medicine, 2021 Diabetes is a complex metabolic disease characterized by hyperglycemia. Its complications are various, often involving the heart, brain, kidney, and other essential organs.
Yiming Qi +5 more
doaj +2 more sources
Mechanistic study of the effect of Endothelin SNPs in microvascular angina – Protocol of the PRIZE Endothelin Sub-Study [PDF]
International Journal of Cardiology: Heart & Vasculature, 2022 Introduction: Microvascular angina is a common cause of ischemia with non-obstructive coronary arteries (INOCA) and limited therapeutic options are available to those affected.
George R. Abraham +7 more
doaj +2 more sources
Coronary Microvascular Angina: A State-of-the-Art Review [PDF]
Frontiers in Cardiovascular Medicine, 2022 Up to 60–70% of patients, undergoing invasive coronary angiography due to angina and demonstrable myocardial ischemia with provocative tests, do not have any obstructive coronary disease. Coronary microvascular angina due to a dysfunction of the coronary
Francesco Spione +5 more
doaj +2 more sources
Comprehensive treatment of microvascular angina in overweight women - a randomized controlled pilot trial. [PDF]
PLoS ONE, 2020 AimsCoronary microvascular dysfunction (CMD) carries a poor cardiovascular prognosis and may explain angina in women without obstructive coronary artery disease (CAD). Currently, no evidence-based treatment for CMD exists.
Kira Bang Bove +6 more
doaj +2 more sources
International prospective cohort study of microvascular angina – Rationale and design [PDF]
International Journal of Cardiology: Heart & Vasculature, 2020 Background: Patients with signs and symptoms of myocardial ischemia and non-obstructive coronary artery disease (CAD) frequently have coronary functional abnormalities, including coronary microvascular dysfunction. Those with the latter are grouped under
Akira Suda +20 more
doaj +2 more sources
Updates on Pharmacologic Management of Microvascular Angina [PDF]
Cardiovascular Therapeutics, 2022 Microvascular angina (MVA), historically called cardiac syndrome X, refers to angina with nonobstructive coronary artery disease. This female-predominant cardiovascular disorder adds considerable health-related costs due to repeated diagnostic ...
Mosayeb Soleymani +5 more
doaj +2 more sources
Continuous Versus Bolus Thermodilution‐Derived Coronary Flow Reserve and Microvascular Resistance Reserve and Their Association With Angina and Quality of Life in Patients With Angina and Nonobstructive Coronaries: A Head‐to‐Head Comparison [PDF]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background Coronary flow reserve (CFR) and microvascular resistance reserve (MRR) are physiological parameters to assess coronary microvascular dysfunction. CFR and MRR can be assessed using bolus or continuous thermodilution, and the correlation between
Tijn P. J. Jansen +11 more
doaj +2 more sources